How this company is disrupting biotech with 30-somethings and industry vets

Ron Leuty
How this company is disrupting biotech with 30-somethings and industry vets

Three young execs and a trio of experienced veterans are trying to move drugs attacking genetic diseases to market faster with a lean model.